The General Objective of This Study is to Monitor, Assess, and Prevent the Potential Medication Errors Among Inpatients in the Tertiary Healthcare Facility of Nepal. This Study Aims to Develop and Implement the Medication Errors Reporting System in Hospital Settings.
NCT ID: NCT07002606
Last Updated: 2025-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
62 participants
OBSERVATIONAL
2025-07-01
2027-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
"Does development and implementation of Medication errors reporting guideline will help to reduce the errors rate and improve the patient safety?"
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing Medication Errors on Basis of an Individual Risk Assessment
NCT01814280
Improving Safety By Computerizing Outpatient Prescribing
NCT00235027
Serious Medication Errors in Pediatrics: Evaluation of Prevention Strategies
NCT00153205
Outpatient Prescription Errors: Detection, Analysis, and Impact on Safety
NCT00256568
Multi-Center Medication Reconciliation Quality Improvement Study
NCT01337063
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
medication errors reporting guidelines
the intervention is designed to reduce the medication errors and develop the culture of reporting the Medication errors in clinical settings.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kathmandu University School of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rudip Thapa
Assistant Professor (Pharmacology)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr. Sony Shakya Professor in Pharmacology, PhD
Role: STUDY_DIRECTOR
Kathmandu University School of Medical Science
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Rudip Thapa Assistant Professor, M.Sc. (Medical) Pharmacology
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PhD- 80/8 t-HS-04
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
147/24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.